All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

ASH 2020 | Practice-changing abstracts in graft-versus-host disease

Feb 11, 2021
Share:

Did you miss ASH 2020? The GvHD Hub attended the 62nd ASH Annual Meeting & Exposition, December 5-8 2020, and has developed a downloadable resource on the practice-changing abstracts in graft-versus-host disease (GvHD).

In this updated resource, you will find comments from the GvHD Hub Steering Committee members on novel treatments, ruxolitinib and belumosudil for steroid-refractory chronic GvHD.

ASH 2020 | Practice-changing abstracts in graft-versus-host disease

If you would like to view the practice-changing abstracts from ASH 2020 and the expert opinions from our Steering Committee, please download the resource below

Download Here

Share: